Navigation Links
China's Leading Healthcare Market Player Records 200% Increase in Profits and Earnings
Date:6/24/2008

HONG KONG, June 25 /Xinhua-PRNewswire-FirstCall/ -- Golden Meditech Company Limited ("Golden Meditech" or the "Group"; Stock Code: 8180.HK) today is pleased to announce its annual results for the financial year ended 31 March 2008. Driven by remarkable organic growth of core businesses and exceptional gains from strategic investments, the Group reported record profit (after-tax) of HK$713,653,000, a jump of 209% over last year. The Group's basic earnings per share increased by 198% to HK44.1 cents.

Turnover of the core businesses rose to HK$421,147,000, representing a rise of 27%. The realized gains from the strategic investments contributed HK$332,435,000 to the Group's profit, up 355% over last year. The Group's net asset value rose to HK$3,553,964,000 at a compound annual growth rate (CAGR) exceeding 47% over the last five years.

Mr. Kam Yuen, Chairman of Golden Meditech said, "We position ourselves as a high-growth, integrated hi-tech medical device and healthcare services enterprise. Golden Meditech is not only the largest blood related medical device manufacturer in China, but also the first and largest umbilical cord blood bank service provider in China. Golden Meditech has also had significant interest in one of the largest natural herbal healthcare chains in England and Ireland -- China Healthcare Inc. (CHI). We intend to maintain a leading dominant position in each of individual business segments."

Among the Group's three core business segments, the Medical Device Segment remained the principle source of the revenue, accounting for 67% of total revenue last year. However, the revenue contribution from the Cord Blood Bank Segment has been steadily rising after consecutive years of high growth, and its share has now rose from last year's 19% to 33% this year. The Medical Device Segment is expected to bring in stable and substantial revenue to the Group whereas the revenue of the Cord Blood Bank Segment will be rapidly increasing.

Golden Meditech's proactive and prudent strategic investments and acquisitions in the past had paid off. One excellent example about our strategic investments was the acquisition of cord blood bank business in 2003. Since the acquisition, the cord blood bank business's newly subscribers had exceeded 100% (CAGR). The Group, had also during the year, successfully brought in new strategic investor in its personal electronic consumer goods sales channel, raising a total of US$90 million at the valuation at 50% above the Group's initial cost. Golden Meditech now owns 37.8% UCMC, the largest medical equipment distributor in China and 33.5% Pypo Digital, a nationwide consumer electronic products distributor.

About Golden Meditech Company Limited

Golden Meditech: Founded in 2000 and listed on the Growth Enterprise Market of the Stock Exchange of Hong Kong Limited in December 2001, Golden Meditech is the first hi-tech medical device enterprise that went public outside of the PRC. During the past few years, thanks to its great efforts in innovation and market expansion, as well as its first-mover abilities in capturing the emerging market opportunities, Golden Meditech's medical device, healthcare services and natural herbal medicines have all established dominant positions in each of its own sectors. Going forward, Golden Meditech will continue its pursuit of becoming China's leading integrated medical group through organic growth, acquisitions and strategic investments.

For enquiries, please contact the investor relations department of Golden Meditech Company Limited.

Contact:

Dennis Haikuan Lu

Investor Relations Manager

Golden Meditech Company Limited (8180.HK)

Tel: +852-3605-8138

Fax: +852-3605-8181

Email: ir@goldenmeditech.com


'/>"/>
SOURCE Golden Meditech Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
4. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
5. Leading-edge body sensor could help produce sporting champions
6. Hospital Quality Info on Web Can Be Misleading
7. AT&T Establishes New Network Services for Leading Medical Liability Insurer
8. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
9. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
10. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
11. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: